Idenix Pharmaceuticals, Inc. (IDIX) Posts Q2 EPS Loss of $0.15, Revenues Miss Expectations
Tweet Send to a Friend
Idenix Pharmaceuticals, Inc. (NASDAQ: IDIX) reported Q2 EPS of ($0.15), $0.02 worse than the analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
